内分泌药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00027654
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计内分泌系统药物市场在 2023 年至 2031 年期间的复合年增长率为 8.50%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告根据产品类型(光学相干断层扫描成像系统、视网膜断层扫描和视网膜血管造影系统、角膜测厚仪、视野测试设备、眼压计等)进行分析。报告按适应症(开角型青光眼、低眼压性青光眼、色素性青光眼、闭角型青光眼等)进行细分。报告进一步根据最终用户(医院、专科诊所、眼科诊断中心、研究机构)提供分析。全球分析进一步细分为区域和主要国家。范围涵盖所有关键细分市场的全球、区域和国家层面的市场规模和预测。报告提供上述分析和细分市场的价值(以美元计算)。报告提供主要市场参与者的市场状况关键统计数据,并提供市场趋势和机会。

报告目的

Insight Partners 的《内分泌系统药物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

内分泌系统药物市场细分

 

类型

  • 糖尿病药物
  • 人类生长激素
  • 甲状腺激素紊乱药物
  • 其他的

应用

  • 医院
  • 诊所
  • 医疗中心

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

内分泌系统药物市场:战略洞察

Endocrine System Drugs Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

内分泌系统药物市场增长动力

  • 激素紊乱发病率不断上升:随着糖尿病、甲状腺和肾上腺疾病等激素紊乱发病率的上升,内分泌系统药物市场已准备好增长。据报道,此类疾病的发病率是由于生活方式的改变、遗传倾向以及各国人口老龄化的情况造成的。患者数量不断增加,因此对有效药物的需求也随之增加,这反过来又促进了针对内分泌系统的药物的生产和销售增长。
  • 药物研发的进步:内分泌药物领域的研发领域不断涌现的先进发展实际上是市场的热点。生物制剂和靶向疗法等新药配方已被证明可用于治疗内分泌疾病。除此之外,生物技术和个性化医疗的进步也解决了一些药物的开发问题,以实现更准确、更有效和个性化的治疗,包括满足患者的需求。
  • 政府举措和健康计划:通过政府健康举措和公共卫生计划,糖尿病等慢性病在人口中得到了很好的控制,这对内分泌系统药物市场产生了巨大的吸引力。因此,这些计划本身就引入了早期发现、治疗可及性甚至预防内分泌相关疾病的政策,所有这些都提高了人们对此类药物的认识和使用。此外,国家对研究改进和未来医疗保健基础设施发展的资助激增也将有助于推动内分泌科药物市场的发展。

内分泌系统药物市场未来趋势

  • 非个性化医疗正在蓬勃发展:内分泌系统药物领域最大的新兴趋势是非个性化医疗。个性化治疗能够通过针对遗传和生物标志物信息的个性化干预,更加精准地针对内分泌疾病。该功能允许医疗保健提供者为患者个性化用药方案,从而改善药物的作用方式并减少不良反应,从而改善患者对内分泌相关疾病的治疗效果。
  • 新兴生物制剂:新兴生物制剂是内分泌系统药物市场不断变化的趋势之一,其中生物制剂、单克隆抗体和其他与糖尿病和甲状腺治疗相关的激素治疗将针对这些疾病。当然,这些药物的副作用通常比传统药物小得多,因此治疗方法变得更加可用,患者管理也得到改善。
  • 远程医疗和数字医疗集成:远程医疗与数字化医疗集成正在成为内分泌系统药物中日益增长的元素之一,使远程监控患者和调整治疗成为可能。移动医疗应用程序和在线咨询是现代医学的重要组成部分,可在患者舒适的家中为客户提供帮助,提高药物依从性和患者知识。因此,这一趋势符合更好的疾病管理(这里是关键的慢性内分泌状态)以及对患者可访问、以患者为中心的医疗保健解决方案的需求

内分泌系统药物市场机会

  • 糖尿病和肥胖症患病率上升:全球糖尿病和肥胖症患病率上升,为内分泌系统药物带来了巨大的市场机遇。随着发病率上升,对血糖调节剂、激素和代谢健康药物的需求也随之增加。这鼓励制药公司创新和扩大其产品组合,以满足不断增长的患者群体的需求。
  • 靶向治疗的进展:医学领域有新的飞地需要发展;新方向是内分泌治疗。这些是革命性的新药物,被称为靶向激素受体途径,因为它们针对的是靶向激素受体途径,疗效更好,副作用更少。这些药物可以归类为精准医疗和生物制剂,用于治疗甲状腺疾病或肾上腺疾病以及生长激素缺乏症,因此成为潜在的市场驱动力。
  • 新兴市场和医疗保健可及性的提高。新兴市场的新医疗保健结构为内分泌系统药物市场提供了机会。随着医疗保健和药品可及性的扩大,接受内分泌相关治疗的患者将越来越多;这反过来又将为寻求进入医疗保健需求不断增长的新兴市场的药品制造商打开更广阔的市场。

 

内分泌系统药物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响内分泌系统药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的内分泌系统药物市场细分和地理位置。

Endocrine System Drugs Market
  • 获取内分泌系统药物市场的区域特定数据

内分泌系统药物市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)8.50%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 糖尿病药物
  • 人类生长激素
  • 甲状腺激素紊乱药物
  • 其他的
按应用
  • 医院
  • 诊所
  • 医疗中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培实验室
  • F.霍夫曼拉罗什有限公司
  • 礼来公司
  • 诺华国际公司
  • 阿拉瑟公司
  • 辉瑞公司
  • Facet Biotec 公司
  • 诺和诺德
  • 赛诺菲

 

内分泌系统药物市场参与者密度:了解其对业务动态的影响

内分泌系统药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在内分泌系统药物市场运营的主要公司有:

  1. 雅培实验室
  2. F.霍夫曼拉罗什有限公司
  3. 礼来公司
  4. 诺华国际公司
  5. 阿拉瑟公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Endocrine System Drugs Market

 

  • 了解内分泌系统药物市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了内分泌系统药物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,内分泌系统药物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Endocrine System Drugs Market ?

The Endocrine System Drugs Market is estimated to witness a CAGR of 8.50% from 2023 to 2031

What are the driving factors impacting the endocrine system drugs market Market?

The major factors driving the endocrine system drugs market Market are:

1.Increasing Prevalence of Chronic Pain

2. Technological Advancements

3. New Product Launches

Which region dominated the endocrine system drugs market Market in 2023?

North America region dominated the endocrine system drugs market Market in 2023

Which region higesh CAGR the endocrine system drugs market Market in 2023?

Asia Pacific region dominated the endocrine system drugs market Market in 2023

Which segment accounts for highest revenue in product type the endocrine system drugs market Market in 2023?

The Rechargeable segment accounts for highest revenue in product the endocrine system drugs market Market in 2023

Which are some of the major players operating in the market?

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Nevro Cor, accounting for higesh market shares and are some of the major players operating in the market

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Abbott Laboratories
- F.Hoffmann LaRoche Ltd.
- Eli Lilly & Company
- Novartis International AG
- Alacer corporation
- Pfizer Inc.
- Facet Biotec Corporation
- Novo Nordisk
- Sanofi
- Merck

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.